Form 4 Tracker
Jonathan Gillis

CAAO and PAO; CAO and Interim CFO · 7 filings · Latest: Oct 15, 2026

MapLight Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
MPLT
Jonathan GillisCAO and Interim CFOOct 15, 2026
Sale
$8.0810,167$82.1K142,315
MPLT
GILLIS JONATHAN—Oct 15, 2026
Proposed Sale
$7.8110,167$79.4K—
MPLT
Jonathan GillisCAO and Interim CFOJul 17, 2026
Sale
$37.6018,469$694.5K144,240
MPLT
Jonathan GillisCAO and Interim CFOJul 16, 2026
Sale
$36.808,455$311.1K162,709
MPLT
Jonathan GillisCAO and Interim CFOJul 15, 2026
Sale
$36.5110,055$367.1K171,164
MPLT
JONATHAN GILLIS—Jul 17, 2026
Proposed Sale
$37.2218,469$687.4K—
MPLT
Jonathan Gillis—Jul 15, 2026
Proposed Sale
$37.9136,979$1.4M—
MPLT
Jonathan GillisCAAO and PAOApr 28, 2026
Sale
$30.3517,935$544.3K181,219
MPLT
Jonathan GillisCAAO and PAOApr 27, 2026
Sale
$29.7451,900$1.5M199,154
MPLT
JONATHAN GILLIS—Apr 27, 2026
Proposed Sale
$29.7669,835$2.1M—
MPLT
Jonathan GillisCAAO and PAOApr 15, 2026
Sale
$26.613,590$95.5K251,054
MPLT
Jonathan Gillis—Apr 15, 2026
Proposed Sale
$27.024,000$108.1K—